Evidence map›Paper›PMID 28663539›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Transcription Factor 21 (TCF21) rs12190287 Polymorphism is Associated with Osteosarcoma Risk and Outcomes in East Chinese Population.

Zhenghui Jiang, Weikang Zhang, Zhikang Chen, Jinxiang Shao, Liqiu Chen, Zhaohui Wang

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Association BetweenInternational journal of general medicine · 2022
    Article
  3. Article
  4. Article
  5. Role of the bHLH transcription factor TCF21 in development and tumorigenesis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Review
  6. Article
  7. Observational
  8. Insulin-Like Growth Factor 1 (IGF1) Pathway Member Polymorphisms Are Associated with Risk and Prognosis of Chondrosarcoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  9. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhenghui JiangDepartment of Orthopaedics, The First People's Hospital of Wenling, Wenling, Zhejiang, China (mainland).
Weikang ZhangDepartment of Orthopaedics, The First People's Hospital of Wenling, Wenling, Zhejiang, China (mainland).
Zhikang ChenDepartment of Epidemiology, School of Public Health, Fudan University, Shanghai, China (mainland).
Jinxiang ShaoDepartment of Orthopaedics, The First People's Hospital of Wenling, Wenling, Zhejiang, China (mainland).
Liqiu ChenDepartment of Orthopaedics, The First People's Hospital of Wenling, Wenling, Zhejiang, China (mainland).
Zhaohui WangDepartment of Orthopaedics, The First People's Hospital of Wenling, Zhejiang, China (mainland).
The First People's Hospital of Wenling · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The transcription factor 21 (TCF21) gene is believed to be a tumor suppressor gene. TCF21 gene polymorphisms were found to play a role in the tumorigenesis of some solid malignancies. We raised a hypothesis that genetic polymorphisms of TCF21 were correlated with risk and prognosis of osteosarcoma. MATERIAL AND METHODS We recruited 225 young osteosarcoma individuals and 250 cancer-free controls. Five tagging SNPs (TCF21 rs2327429 T>C, rs2327433 A>G, rs2327433 A>G, rs12190287 C>G, and rs4896011 T>A) were genotyped. Preserved DNA samples from blood underwent PCR analysis for genotyping. RESULTS rs12190287 C>G is a good predictor of osteosarcoma risk and outcomes. The CG and GG genotypes of rs12190287 predict elevated risk of osteosarcoma. Besides, rs12190287 CG and GG genotypes are associated with Enneking stage and potential in forming metastasis of osteosarcoma. CONCLUSIONS Genetic polymorphisms of TCF21 are potentially predictive for osteosarcoma risk and outcomes.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdolescentAsian PeopleBasic Helix-Loop-Helix ProteinsConfounding Factors, EpidemiologicFemaleGenome, HumanHaplotypesHumansLogistic ModelsMaleNeoplasm MetastasisOsteosarcomaPolymorphism, Single NucleotideRisk FactorsBasic Helix-Loop-Helix ProteinsTCF21 protein, human

Identifiers

PMID28663539
PMCPMC5503230
OpenAlexW2728367147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.